Cargando…

An Atypical HNF4A Mutation Which Does Not Conform to the Classic Presentation of HNF4A-MODY

OBJECTIVE: To present the case of an atypical Hepatocyte Nuclear Factor 4 Alpha (HNF4A) mutation that is not consistent with the classically published presentation of HNF4A-Mature Onset Diabetes of the Young (MODY). METHODS: Clinical presentation and literature review. RESULTS: A 43-year-old nonobes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spiro, Andrew J., Vu, Katherine N., Warnock, Alicia Lynn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994579/ https://www.ncbi.nlm.nih.gov/pubmed/29998026 http://dx.doi.org/10.1155/2018/1560472

Ejemplares similares

Double Heterozygous Mutations Involving Both HNF1A/MODY3 and HNF4A/MODY1 Genes: A case report
por: Forlani, Gabriele, et al.
Publicado: (2010)

Reduced penetrance of MODY-associated HNF1A/HNF4A variants but not GCK variants in clinically unselected cohorts
por: Mirshahi, Uyenlinh L, et al.
Publicado: (2022)

Efficacy of metformin versus sulfonylurea derivative in HNF4A-MODY
por: Oosterom, Nicole, et al.
Publicado: (2022)

Novel Use of GLP-1 Receptor Agonist Therapy in HNF4A-MODY
por: Broome, David T., et al.
Publicado: (2020)

Variants influencing age at diagnosis of HNF1A-MODY
por: Ludwig-Słomczyńska, Agnieszka H., et al.
Publicado: (2022)

A Comprehensive Analysis of Hungarian MODY Patients—Part I: Gene Panel Sequencing Reveals Pathogenic Mutations in HNF1A, HNF1B, HNF4A, ABCC8 and INS Genes
por: Gaál, Zsolt, et al.
Publicado: (2021)

Association of birthweight and penetrance of diabetes in individuals with HNF4A-MODY: a cohort study
por: Locke, Jonathan M., et al.
Publicado: (2021)

Species-Specific Differences in the Expression of the HNF1A, HNF1B and HNF4A Genes
por: Harries, Lorna W., et al.
Publicado: (2009)

Circulating CD36 Is Reduced in HNF1A-MODY Carriers
por: Bacon, Siobhan, et al.
Publicado: (2013)

MON-646 Novel Use of GLP-1 Receptor Agonist Therapy in MODY-1 (HNF4A Mutation)
por: Broome, David Tyler, et al.
Publicado: (2020)

Cystatin C is not a good candidate biomarker for HNF1A-MODY
por: Nowak, Natalia, et al.
Publicado: (2012)

Granuloma annulare and necrobiosis lipoidica in a patient with HNF1A-MODY
por: Brandes, Gabriela Irene Garcia, et al.
Publicado: (2022)

Genetic and Clinical Characterization of Patients with HNF1B-Related MODY in Croatia
por: Baretić, Maja, et al.
Publicado: (2023)

Structural insights into the HNF4 biology
por: Beinsteiner, Brice, et al.
Publicado: (2023)

Identification and precision therapy for three maturity-onset diabetes of the young (MODY) families caused by mutations in the HNF4A gene
por: Zhang, Juan, et al.
Publicado: (2023)

Disruption of Tumor Suppressors HNF4α/HNF1α Causes Tumorigenesis in Liver
por: Teeli, Aamir Salam, et al.
Publicado: (2021)

Circulating ghrelin level is higher in HNF1A–MODY and GCK–MODY than in polygenic forms of diabetes mellitus
por: Nowak, Natalia, et al.
Publicado: (2015)

Incidence of HNF1A and GCK MODY Variants in a South African Population
por: Matsha, Tandi E, et al.
Publicado: (2020)

Crystallization of hepatocyte nuclear factor 4α (HNF4α) in complex with the HNF1α promoter element
por: Lu, Peng, et al.
Publicado: (2008)

Epistasis of Transcriptomes Reveals Synergism between Transcriptional Activators Hnf1α and Hnf4α
por: Boj, Sylvia F., et al.
Publicado: (2010)

Two Cases of Diabetic Ketoacidosis in HNF1A-MODY Linked to Severe Dehydration: Is it time to change the diagnostic criteria for MODY?
por: Pruhova, Stepanka, et al.
Publicado: (2013)

High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes
por: McDonald, Tim J., et al.
Publicado: (2011)

MODY probability calculator for GCK and HNF1A screening in a multiethnic background population
por: Tarantino, Roberta Magalhães, et al.
Publicado: (2019)

Molecular Dynamics Simulations Predict that rSNP Located in the HNF-1α Gene Promotor Region Linked with MODY3 and Hepatocellular Carcinoma Promotes Stronger Binding of the HNF-4α Transcription Factor
por: Španinger, Eva, et al.
Publicado: (2020)

LncRNA Hnf4αos exacerbates liver ischemia/reperfusion injury in mice via Hnf4αos/Hnf4α duplex-mediated PGC1α suppression
por: Wang, Chaoqun, et al.
Publicado: (2022)

Identification of a novel hepatocyte nuclear factor-1 alpha (HNF1A) variant in maturity onset diabetes of the young type 3 (HNF1A-MODY)
por: Verma, Megha, et al.
Publicado: (2022)

Maturity-onset diabetes of the young secondary to HNF1B variants (HNF1B-MODY): a series of 10 patients from a single diabetes center
por: Amaral, Sara, et al.
Publicado: (2023)

Inhibitory effects of HNF4α on migration/maltransformation of hepatic progenitors: HNF4α-overexpressing hepatic progenitors for liver repopulation
por: Wang, Ping, et al.
Publicado: (2017)

Liver fat storage is controlled by HNF4α through induction of lipophagy and is reversed by a potent HNF4α agonist
por: Lee, Seung-Hee, et al.
Publicado: (2021)

A multigenerational study on phenotypic consequences of the most common causal variant of HNF1A-MODY
por: Kettunen, Jarno L. T., et al.
Publicado: (2021)

HNF1B-MODY Masquerading as Type 1 Diabetes: A Pitfall in the Etiological Diagnosis of Diabetes
por: Francis, Youmna, et al.
Publicado: (2022)

Clinical Characteristics of Patients With HNF1-alpha MODY: A Literature Review and Retrospective Chart Review
por: Zhao, Qinying, et al.
Publicado: (2022)

HNF4alpha and HNF1alpha Dysfunction as a Molecular Rational for Cyclosporine Induced Posttransplantation Diabetes Mellitus
por: Borlak, Jürgen, et al.
Publicado: (2009)

HNF4A Haploinsufficiency in MODY1 Abrogates Liver and Pancreas Differentiation from Patient-Derived Induced Pluripotent Stem Cells
por: Ng, Natasha Hui Jin, et al.
Publicado: (2019)

Development of an exoglycosidase plate-based assay for detecting α1-3,4 fucosylation biomarker in individuals with HNF1A-MODY
por: Demus, Daniel, et al.
Publicado: (2021)

HNF4A modulates glucocorticoid action in the liver
por: Hunter, A. Louise, et al.
Publicado: (2022)

The protein architecture and allosteric landscape of HNF4α
por: Rastinejad, Fraydoon
Publicado: (2023)

A Case of Novel Mutation of HNF1B in Maturity-onset Diabetes of the Young Type 5 (MODY5)
por: Jo, Wakako, et al.
Publicado: (2012)

A potent HNF4α agonist reveals that HNF4α controls genes important in inflammatory bowel disease and Paneth cells
por: Lee, Seung-Hee, et al.
Publicado: (2022)

The Roles of Long Noncoding RNAs HNF1α-AS1 and HNF4α-AS1 in Drug Metabolism and Human Diseases
por: Chen, Liming, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mdjvsvd7938486jme7v54fl61c